Literature DB >> 25722492

Effects of posterior vitreous detachment on aqueous humour levels of VEGF and inflammatory cytokines.

Hidenori Takahashi1, Yoko Nomura2, Xue Tan2, Yujiro Fujino3, Hidetoshi Kawashima4, Yasuo Yanagi2.   

Abstract

PURPOSE: To investigate the association of posterior vitreous detachment (PVD) with aqueous levels of vascular endothelial growth factor (VEGF) and other inflammatory cytokines.
METHODS: These are prospective comparative studies. Subjects comprised 98 eyes for VEGF concentration and 80 eyes for other cytokines, which are normal except for cataract. PVD was examined by B-mode ultrasonography, and the subjects were divided into complete PVD group (PVD group) or the other group (without PVD group). At the beginning of cataract surgery, aqueous humour was collected and the concentrations of VEGF and other inflammatory cytokines were determined using ELISA and a multiplex cytokine assay, respectively. The concentrations of these cytokines were compared between the two groups.
RESULTS: Complete PVD was observed in 56 (57%) eyes for VEGF concentration analysis, and 51 (64%) eyes for the other cytokines analysis. The concentrations of VEGF, adjusted for the average age, axial length and gender distribution, was 47 pg/mL in the PVD group and 72 pg/mL in the without PVD group. The concentrations of IP-10, MCP-1, CXCL13 and CCL11 were 53, 450, 3.8 and 6.0 pg/mL in the PVD group, and 100, 560, 7.0 and 8.4 pg/mL in the without PVD group, respectively. Multiple regression analysis revealed that the logarithmic concentration of VEGF, IP-10, MCP-1, CXCL13 and CCL11 were significantly lower in the eyes with PVD than in those without PVD independently of age, sex and axial length (p=0.01, p=0.002, p=0.009, 0.006 and 0.03, respectively).
CONCLUSIONS: PVD is related to the change in the multiple intraocular inflammatory cytokines. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Aqueous humour; Inflammation; Macula; Neovascularisation; Vitreous

Mesh:

Substances:

Year:  2015        PMID: 25722492     DOI: 10.1136/bjophthalmol-2014-306051

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

Review 1.  A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration.

Authors:  U Schmidt-Erfurth; S Klimscha; S M Waldstein; H Bogunović
Journal:  Eye (Lond)       Date:  2016-11-25       Impact factor: 3.775

2.  Vitreo-macular interface disorders in retinitis pigmentosa.

Authors:  Serena Fragiotta; Tommaso Rossi; Carmela Carnevale; Alessandro Cutini; Stefano Tricarico; Lorenzo Casillo; Gianluca Scuderi; Enzo Maria Vingolo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-19       Impact factor: 3.117

3.  Microvolume Analysis of Aflibercept in Aqueous Humor Using Mass Spectrometry.

Authors:  Natsuka Kimura; Hidenori Takahashi; Shinichi Sakamoto; Yasuo Yanagi; Nozomi Maeshima; Ayaka Minamimoto; Noriko Iwamoto; Takashi Shimada; Ryozo Nagai; Kenichi Aizawa
Journal:  Transl Vis Sci Technol       Date:  2022-06-01       Impact factor: 3.048

4.  Aqueous Humor Analyses in Patients with Diabetic Retinopathy Who Had Undergone Panretinal Photocoagulation.

Authors:  Jin-Woo Kwon; Jusang Oh
Journal:  J Diabetes Res       Date:  2022-06-20       Impact factor: 4.061

5.  Evaluating the impact of vitreomacular adhesion on anti-VEGF therapy for retinal vein occlusion using machine learning.

Authors:  Sebastian M Waldstein; Alessio Montuoro; Dominika Podkowinski; Ana-Maria Philip; Bianca S Gerendas; Hrvoje Bogunovic; Ursula Schmidt-Erfurth
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

6.  Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema.

Authors:  Rodolfo Mastropasqua; Rossella D'Aloisio; Marta Di Nicola; Giuseppe Di Martino; Alessia Lamolinara; Luca Di Antonio; Daniele Tognetto; Lisa Toto
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

7.  Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema.

Authors:  Edoardo Midena; Alessandra Micera; Luisa Frizziero; Elisabetta Pilotto; Graziana Esposito; Silvia Bini
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

8.  Ocular inflammation after agitation of siliconized and silicone oil-free syringes: a randomized, double-blind, controlled clinical trial.

Authors:  Natasha Ferreira Santos da Cruz; Murilo Ubukata Polizelli; Felipe Picanço Muralha; Clarice Neuenschwander Lins de Morais; Octaviano Magalhães Silva Junior; Mauricio Maia; Gustavo Barreto Melo; Michel Eid Farah
Journal:  Int J Retina Vitreous       Date:  2022-06-17

9.  Changes in multiple cytokine concentrations in the aqueous humour of neovascular age-related macular degeneration after 2 months of ranibizumab therapy.

Authors:  Shinichi Sakamoto; Hidenori Takahashi; Xue Tan; Yuji Inoue; Yoko Nomura; Yusuke Arai; Yujiro Fujino; Hidetoshi Kawashima; Yasuo Yanagi
Journal:  Br J Ophthalmol       Date:  2017-08-01       Impact factor: 4.638

10.  Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration.

Authors:  Yusuke Arai; Hidenori Takahashi; Satoru Inoda; Xue Tan; Shinichi Sakamoto; Yuji Inoue; Yujiro Fujino; Hidetoshi Kawashima; Yasuo Yanagi
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.